APO866 activity in hematologic malignancies: a preclinical in vitro study

被引:23
作者
Cea, Michele [1 ]
Zoppoli, Gabriele [1 ]
Bruzzone, Santina [1 ]
Fruscione, Floriana [1 ]
Moran, Eva [1 ]
Garuti, Anna [1 ]
Rocco, Ilaria [1 ]
Cirmena, Gabriella [1 ]
Casciaro, Salvatore [1 ]
Olcese, Francesca [1 ]
Pierri, Ivana [1 ]
Cagnetta, Antonia [1 ]
Ferrando, Fabio [1 ]
Ghio, Riccardo [1 ]
Gobbi, Marco [1 ]
Ballestrero, Alberto [1 ]
Patrone, Franco [1 ]
Nencioni, Alessio [1 ]
机构
[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy
关键词
INHIBITOR;
D O I
10.1182/blood-2009-03-209213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:6035 / 6037
页数:3
相关论文
共 5 条
[1]   Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes [J].
Bruzzone, S ;
Moreschi, I ;
Guida, L ;
Usai, C ;
Zocchi, E ;
De Flora, A .
BIOCHEMICAL JOURNAL, 2006, 393 (697-704) :697-704
[2]  
Hasmann M, 2003, CANCER RES, V63, P7436
[3]   The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies [J].
Nahimana, Aimable ;
Attinger, Antoine ;
Aubry, Dominique ;
Greaney, Peter ;
Ireson, Christopher ;
Thougaard, Annemette V. ;
Tjornelund, Jette ;
Dawson, Keith M. ;
Dupuis, Marc ;
Duchosal, Michel A. .
BLOOD, 2009, 113 (14) :3276-3286
[4]   Sulforhodamine B colorimetric assay for cytotoxicity screening [J].
Vichai, Vanicha ;
Kirtikara, Kanyawim .
NATURE PROTOCOLS, 2006, 1 (03) :1112-1116
[5]  
VISTICA DT, 1991, CANCER RES, V51, P2515